Exact Mass: 499.1604
Exact Mass Matches: 499.1604
Found 331 metabolites which its exact mass value is equals to given mass value 499.1604
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
5-O-(Indol-3-ylacetyl-myo-inositol) D-galactoside
Halofantrine
Halofantrine is a drug used to treat malaria. It belongs to the phenanthrene class of compounds that includes quinine and lumefantrine. It appears to inhibit polymerisation of heme molecules (by the parasite enzyme heme polymerase), resulting in the parasite being poisoned by its own waste. Halofantrine has been shown to preferentially block open and inactivated HERG channels leading to some degree of cardiotoxicity. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
13-Deoxycarminomycin
A cytotoxic anthracycline antibiotic that is produced by Streptomyces peucetius var. carminatus (a biochemical mutant of Streptomyces peucetius var. caesius), and is active against P-388 murine leukemia.
Suplatast Tosilate
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D018926 - Anti-Allergic Agents
CDK9 inhibitor
Glucose lactate pyruvate glutamate
Idarubicinol
Tyr-Gly-Gly-Phe-Gly-OH
Palygorskite
It is used in foods as a clarifying and flocculating agent [DFC]
Serdexmethylphenidate
C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
Ser His Gln Glu
N-[4,5-dihydroxy-2-[[4-[hydroxy(phenyl)methyl]-5-oxo-3-phenyl-2H-furan-2-yl]oxy]-6-(methoxymethyl)oxan-3-yl]acetamide
N-[4,5-dihydroxy-2-[[4-[hydroxy(phenyl)methyl]-5-oxo-3-phenyl-2H-furan-2-yl]oxy]-6-(methoxymethyl)oxan-3-yl]acetamide
N-[4,5-dihydroxy-2-[[4-[hydroxy(phenyl)methyl]-5-oxo-3-phenyl-2H-furan-2-yl]oxy]-6-(methoxymethyl)oxan-3-yl]acetamide [IIN-based on: CCMSLIB00000848988]
N-[4,5-dihydroxy-2-[[4-[hydroxy(phenyl)methyl]-5-oxo-3-phenyl-2H-furan-2-yl]oxy]-6-(methoxymethyl)oxan-3-yl]acetamide [IIN-based: Match]
Cys Cys Phe Lys
Cys Cys Phe Gln
Cys Cys Lys Phe
Cys Cys Gln Phe
Cys Phe Cys Lys
Cys Phe Cys Gln
Cys Phe Lys Cys
Cys Phe Gln Cys
Cys Lys Cys Phe
Cys Lys Phe Cys
Cys Lys Ser Tyr
Cys Lys Tyr Ser
Cys Asn Thr Tyr
Cys Asn Tyr Thr
Cys Gln Cys Phe
Cys Gln Phe Cys
Cys Gln Ser Tyr
Cys Gln Tyr Ser
Cys Ser Lys Tyr
Cys Ser Gln Tyr
Cys Ser Tyr Lys
Cys Ser Tyr Gln
Cys Thr Asn Tyr
Cys Thr Tyr Asn
Cys Tyr Lys Ser
Cys Tyr Asn Thr
Cys Tyr Gln Ser
Cys Tyr Ser Lys
Cys Tyr Ser Gln
Cys Tyr Thr Asn
Asp Asp His Asn
Asp Asp Asn His
Asp His Asp Asn
Asp His Asn Asp
Asp His Gln Thr
Asp His Thr Gln
Asp Asn Asp His
Asp Asn His Asp
Asp Gln His Thr
Asp Gln Thr His
Asp Thr His Gln
Asp Thr Gln His
Glu His Asn Thr
Glu His Gln Ser
Glu His Ser Gln
Glu His Thr Asn
Glu Asn His Thr
Glu Asn Thr His
Glu Gln His Ser
Glu Gln Ser His
Glu Ser His Gln
Glu Ser Gln His
Glu Thr His Asn
Glu Thr Asn His
Phe Cys Cys Lys
Phe Cys Cys Gln
Phe Cys Lys Cys
Phe Cys Gln Cys
Phe Gly Asn Tyr
Phe Gly Tyr Asn
Phe Lys Cys Cys
Phe Asn Gly Tyr
Phe Asn Tyr Gly
Phe Gln Cys Cys
Phe Tyr Gly Asn
Phe Tyr Asn Gly
Gly Phe Asn Tyr
Gly Phe Tyr Asn
Gly Asn Phe Tyr
Gly Asn Tyr Phe
Gly Tyr Phe Asn
Gly Tyr Asn Phe
His Asp Asp Asn
His Asp Asn Asp
His Asp Gln Thr
His Asp Thr Gln
His Glu Asn Thr
His Glu Gln Ser
His Glu Ser Gln
His Glu Thr Asn
His Asn Asp Asp
His Asn Glu Thr
His Asn Thr Glu
His Gln Asp Thr
His Gln Glu Ser
His Gln Ser Glu
His Gln Thr Asp
His Ser Glu Gln
His Ser Gln Glu
His Thr Asp Gln
His Thr Glu Asn
His Thr Asn Glu
His Thr Gln Asp
Lys Cys Cys Phe
Lys Cys Phe Cys
Lys Cys Ser Tyr
Lys Cys Tyr Ser
Lys Phe Cys Cys
Lys Ser Cys Tyr
Lys Ser Tyr Cys
Lys Tyr Cys Ser
Lys Tyr Ser Cys
Asn Cys Thr Tyr
Asn Cys Tyr Thr
Asn Asp Asp His
Asn Asp His Asp
Asn Glu His Thr
Asn Glu Thr His
Asn Phe Gly Tyr
Asn Phe Tyr Gly
Asn Gly Phe Tyr
Asn Gly Tyr Phe
Asn His Asp Asp
Asn His Glu Thr
Asn His Thr Glu
Asn Thr Cys Tyr
Asn Thr Glu His
Asn Thr His Glu
Asn Thr Tyr Cys
Asn Tyr Cys Thr
Asn Tyr Phe Gly
Asn Tyr Gly Phe
Asn Tyr Thr Cys
Gln Cys Cys Phe
Gln Cys Phe Cys
Gln Cys Ser Tyr
Gln Cys Tyr Ser
Gln Asp His Thr
Gln Asp Thr His
Gln Glu His Ser
Gln Glu Ser His
Gln Phe Cys Cys
Gln His Asp Thr
Gln His Glu Ser
Gln His Ser Glu
Gln His Thr Asp
Gln Ser Cys Tyr
Gln Ser Glu His
Gln Ser His Glu
Gln Ser Tyr Cys
Gln Thr Asp His
Gln Thr His Asp
Gln Tyr Cys Ser
Gln Tyr Ser Cys
Ser Cys Lys Tyr
Ser Cys Gln Tyr
Ser Cys Tyr Lys
Ser Cys Tyr Gln
Ser Glu His Gln
Ser Glu Gln His
Ser His Glu Gln
Ser Lys Cys Tyr
Ser Lys Tyr Cys
Ser Gln Cys Tyr
Ser Gln Glu His
Ser Gln His Glu
Ser Gln Tyr Cys
Ser Tyr Cys Lys
Ser Tyr Cys Gln
Ser Tyr Lys Cys
Ser Tyr Gln Cys
Thr Cys Asn Tyr
Thr Cys Tyr Asn
Thr Asp His Gln
Thr Asp Gln His
Thr Glu His Asn
Thr Glu Asn His
Thr His Asp Gln
Thr His Glu Asn
Thr His Asn Glu
Thr His Gln Asp
Thr Asn Cys Tyr
Thr Asn Glu His
Thr Asn His Glu
Thr Asn Tyr Cys
Thr Gln Asp His
Thr Gln His Asp
Thr Tyr Cys Asn
Thr Tyr Asn Cys
Tyr Cys Lys Ser
Tyr Cys Asn Thr
Tyr Cys Gln Ser
Tyr Cys Ser Lys
Tyr Cys Ser Gln
Tyr Cys Thr Asn
Tyr Phe Gly Asn
Tyr Phe Asn Gly
Tyr Gly Phe Asn
Tyr Gly Asn Phe
Tyr Lys Cys Ser
Tyr Lys Ser Cys
Tyr Asn Cys Thr
Tyr Asn Phe Gly
Tyr Asn Gly Phe
Tyr Asn Thr Cys
Tyr Gln Cys Ser
Tyr Gln Ser Cys
Tyr Ser Cys Lys
Tyr Ser Cys Gln
Tyr Ser Lys Cys
Tyr Ser Gln Cys
Tyr Thr Cys Asn
Tyr Thr Asn Cys
4-[Hydroxy(phenyl)methyl]-5-oxo-3-phenyl-2,5-dihydro-2-furanyl 2-acetamido-2-deoxy-6-O-methylhexopyranoside
methyl 4-cyano-5-[[5-cyano-2,6-bis[(3-methoxypropyl)amino]-4-methyl-3-pyridyl]azo]-3-methyl-2-thenoate
Fosquidone
C274 - Antineoplastic Agent > C177298 - Mitochondrial Targeting Antineoplastic Agent C26170 - Protective Agent > C275 - Antioxidant
1,4,8-Tris(aminocarbonylmethyl)-1,4,8,11-tetraazacyclotetradecane monohydriodide
Ranolazine dihydrochloride
C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
N-[4-(aminocarbonyl)phenyl]-4-[[1-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-oxopropyl]azo]benzamide
(4Z)-4-[[4-[[4-[bis(2-hydroxyethyl)amino]phenyl]diazenyl]phenyl]hydrazinylidene]-3-oxonaphthalene-2-carboxylic acid
N-{4-[(2-Methyl-4,5-dihydro-6H-[1,3]oxazolo[4,5-d][1]benzazepin-6-yl)carbonyl]phenyl}-2-biphenylcarboxamide
Firategrast
C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D007155 - Immunologic Factors > D007136 - Immunoglobulins D007155 - Immunologic Factors > D000906 - Antibodies
2-(3,4-Difluorophenoxy)-5-fluoro-N-(cis-4-((2-hydroxy-5-methylbenzoyl)amino)cyclohexyl)nicotinamide
Lubabegron
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent Lubabegron is a potent modulator of β-adrenergic receptor (β -AR). Lubabegron demonstrates antagonistic behavior at the β1 and β?2 receptor subtypes and agonistic behavior at the β?3 receptor subtype in cattle. Lubabegron reduces NH3 gas emissions from an animal or its waste[1].
Pivampicillin hydrochloride
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Zofenoprilat arginine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor
N-{2-[4-(aminosulfonyl)phenyl]ethyl}-2-[(2-isopropyl-3-oxo-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)thio]acetamide
n-[4-[[Glutamic acid]-carbonyl]-benzene-sulfonyl-d-prolinyl]-3-amino-propanoic acid
3-(5-Amino-7-hydroxy-[1,2,3]triazolo[4,5-D]pyrimidin-2-YL)-N-[2-(2-(hydroxymethyl-phenylsulfanyl)-benzyl]-benzamide
N-(2H-benzotriazol-5-yl)-7-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]quinolin-4-amine
(2R)-2-amino-4-{4-[(1E)-{[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl}(hydroxyimino)methyl]phenoxy}butanoate
[(1R,2R,3R,4R,5S,6R)-2,3,4,5-tetrahydroxy-6-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexyl] 2-(1H-indol-3-yl)acetate
(2S)-2-amino-4-{4-[(1E)-{[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl}(hydroxyimino)methyl]phenoxy}butanoate
5-O-(2-hydroxypropanoyl) 1-O-(2-oxopropanoyl) 2-amino-2-[2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]pentanediperoxoate
(2S)-2-[3-[3-(trifluoromethyl)-4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide
N-(1,3-benzodioxol-5-ylmethyl)-1-ethyl-6-(4-morpholinylsulfonyl)-4-oxo-3-quinolinecarboxamide
2-[(2-Benzotriazol-1-yl-acetyl)-furan-2-ylmethyl-amino]-N-furan-2-ylmethyl-2-(3-methoxy-phenyl)-acetamide
4-Methyl-7-[[4-[[4-(4-nitrophenyl)-1-piperazinyl]-oxomethyl]phenyl]methoxy]-1-benzopyran-2-one
3-[[2-[[5-[(4-Cyanophenoxy)methyl]-4-phenyl-1,2,4-triazol-3-yl]thio]-1-oxoethyl]amino]benzoic acid methyl ester
1-(1,3-benzodioxol-5-ylmethyl)-3-(4-methylphenyl)-1-[(7-oxo-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-8-yl)methyl]urea
1-methyl-5-(piperidin-1-ylsulfonyl)-1H-indole-3-carbaldehyde N-(2-ethoxyphenyl)thiosemicarbazone
8-chloro-1-methyl-2,6-dioxo-7H-purine-3-carboxylic acid 2-(diphenylmethyl)oxy-N,N-dimethylethanamine
[(1R)-2-(1,3-benzodioxol-5-ylmethyl)-1-ethylsulfonyl-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
3-(2-fluorophenyl)-1-[(2R,3S)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2S)-1-hydroxypropan-2-yl]urea
3-(2-fluorophenyl)-1-[(2S,3R)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2R)-1-hydroxypropan-2-yl]urea
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-7-pyridin-4-yl-1-(pyridin-4-ylmethyl)-N-(2,2,2-trifluoroethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
3-(2-fluorophenyl)-1-[(2R,3R)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2S)-1-hydroxypropan-2-yl]urea
3-(2-fluorophenyl)-1-[(2R,3S)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2R)-1-hydroxypropan-2-yl]urea
3-(2-fluorophenyl)-1-[(2S,3R)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2S)-1-hydroxypropan-2-yl]urea
3-(2-fluorophenyl)-1-[(2S,3S)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2R)-1-hydroxypropan-2-yl]urea
3-(2-fluorophenyl)-1-[(2S,3S)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2S)-1-hydroxypropan-2-yl]urea
3-(2-fluorophenyl)-1-[(2R,3R)-4-[(4-fluorophenyl)sulfonyl-methylamino]-3-methoxy-2-methylbutyl]-1-[(2R)-1-hydroxypropan-2-yl]urea
N-[(2R,4aS,12aS)-2-[2-(4-chloroanilino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-methylpropanamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-6-oxo-7-pyridin-4-yl-1-(pyridin-4-ylmethyl)-N-(2,2,2-trifluoroethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
[(1S)-2-(1,3-benzodioxol-5-ylmethyl)-1-ethylsulfonyl-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
4-(4-Chlorobenzoyl)-1-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-5-phenylpyrrolidine-2,3-dione
(2R)-2-amino-4-[4-[(Z)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-oxidocarbonimidoyl]phenoxy]butanoic acid
(2S)-2-amino-4-[4-[(Z)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-oxidocarbonimidoyl]phenoxy]butanoic acid
[3-methoxy-2-[methyl-[(E)-10,16,16-trichlorohexadec-4-enoyl]amino]propyl] acetate
Halofantrine
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
[(2S,3S,5R,6R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-cyclohexyl] 2-(1H-indol-3-yl)acetate
nocardicin A(1-)
An alpha-amino-acid anion that is the conjugate base of nocardicin A, arising from deprotonation of the carboxy groups and protonation of the amino group.
isonocardicin A(1-)
Conjugate base of isonocardicin A zwitterion where both carboxy groups are deprotonated while the homoserine amino group is protonated.
Osteogenic Growth Peptide (10-14)
Osteogenic Growth Peptide (10-14) (OGP(10-14)), the C-terminal truncated pentapeptide of osteogenic growth peptide (OGP), retains the full OGP-like activity. Osteogenic Growth Peptide (10-14) is responsible for the binding to the OGP receptor and activates an intracellular Gi-protein-MAP kinase signaling pathway. Osteogenic Growth Peptide (10-14) is a potent mitogen and stimulator of osteogenesis and hematopoiesis. Osteogenic Growth Peptide (10-14) acts as a Src inhibitor[1][2][3][4].
RMC-0331
RMC-0331 (RM-023) is a potent, selective and orally bioavailable SOS1 inhibitor. RMC-0331 is an in vivo tool compound that blocks RAS activation via disruption of the RAS-SOS1 interaction[1].